Antiplatelet and Anticoagulant Risk for Select Spine Interventions: A Retrospective Cohort

Abstract

This cohort adds to the growing evidence that the risk of serious bleeding complications from select spine interventions while continuing medications with antiplatelet or anticoagulant effect appears low.